Faculty profile

Victor Lewis

ResearcherPediatricsUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.

Victor Lewis

Researcher

Pediatrics

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
10 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

215

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adenine Base Editing Gene Editing Gene Therapy Clinical Trial Inborn Errors Of Immunity Rare Diseases Severe Combined Immune Deficiency

Latest papers

Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study
The Lancet Haematology · 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Nature cancer · 2026
IL1B rs1143627 and IL17A rs8193036 in the risk of Acute Graft Versus Host Disease in pediatric HSCT.
Leukemia research · 2026

All 35 publications

Latest funding

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.
CIHR · 2022 · Principal investigator
$606,576
A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.
CIHR · 2022 · Principal investigator
$2,426,302
The Pain Squad+ Smartphone App To Support Real-Time Pain Management for Adolescents with Cancer: A Randomized Controlled Trial
CIHR · 2017 · Co-investigator
$573,752

All 3 grants and awards

35 publications.

Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study

Gruber TA, Jeha S, Deyell RJ, Lewis V, Chang BH, Lowe EJ, Frediani J, Vezina C, Michon B, Richards M

The Lancet Haematology20261 citations

DOI: 10.1016/s2352-3026(25)00357-6

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Zemp FJ, Breckenridge Z, Song H, Gill GS, Louie TL, Narta K, Liu H, Suh Y, Guignard L, Mandujano-Tinoco EA, Collao N, Pyczek J, Ellestad KK, Curry J, Langley J, John C, Mah LK, Rajwani J, Evseev D, Turk M, Benaoudia S, Alex J, Naumenko V, Manoharan VT, Mehrabadi MK, Smith HA, Gilbert GNY, Gillmor A, Verhey TB, Todesco HM, Osz K, Ahn BY, Bogossian A, Anderson C, Sikdar S, Rukunuddin S, Bismar TA, Heng DYC, Lawson K, Linehan WM, Pedersen H, Gordon PMK, McIntyre JB, MacGregor J, Garzia L, Brodeur-Robb K, DiFrancesco L, Ogilvie T, Schöffski P, Wozniak A, Holt RA, Bell J, Senger DL, Lewis V, Monument M, Khan O, Baudrier L, Billon P, Gabriel V, Biernaskie J, Potts K, Trpkov K, Hay K, Quizi J, Chan J, Saleh R, Henning JW, Prokopishyn NL, Shafey M, Morrissy AS, Mahoney DJ

Nature cancer2026

DOI: 10.1038/s43018-026-01194-3 PMID: 42387022

IL1B rs1143627 and IL17A rs8193036 in the risk of Acute Graft Versus Host Disease in pediatric HSCT.

Mootoosamy C, Ansari M, Gagné V, Chatelain-Laflamme A, Flament C, Zekraoui O, Nyambi M, Théorêt Y, Nava T, Mlakar V, Gloor YS, Villard J, Boelens JJ, Bredius RGM, Dalle JH, Lewis V, Kałwak K, Sinnett D, Bittencourt H, Krajinovic M

Leukemia research2026

DOI: 10.1016/j.leukres.2026.108189 PMID: 41775174

Approach to red cell transfusions and stem cell transplant in an alloimmunized sickle cell patient with hyperhemolysis history.

Tehseen S, Martin G, Gupta A, Lewis V

Transfusion2026Senior author

DOI: 10.1111/trf.70358 PMID: 42786794

Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children's Oncology Group study ACNS0333.

Aridgides P, Mahajan A, Merchant TE, Krailo M, Buxton A, Deck J, Strother D, Huang A, Biegel JA, Ho B, Mazewski C, Lewis V, Pollack IF, Leary SES, Fouladi M, Reddy AT

Neuro-oncology pediatrics2026

DOI: 10.1093/neuped/wuaf015 PMID: 42181026

HLA-B15:01 and HLA-DRB107:01 as novel markers of acute GVHD in pediatric HSCT.

Mootoosamy C, Ansari M, Gagné V, St-Onge P, Tremblay-Dauphinais P, Beaulieu P, Théorêt Y, Nava T, Mlakar V, Gloor YS, Villard J, Boelens JJ, Bredius RGM, Dalle JH, Lewis V, Kałwak K, Sinnett D, Bittencourt H, Krajinovic M, Pediatric Disease Working Parties of the European Blood and Bone Marrow Transplant Group

Bone marrow transplantation2026

DOI: 10.1038/s41409-026-02972-4 PMID: 42457985

Yoga versus iPad active control for fatigue in paediatric cancer therapy: a randomised controlled trial.

Schechter T, Tardif-Theriault C, Culos-Reed N, Lewis V, Orsey A, Diorio C, Tomlinson GA, Sung L

BMJ supportive & palliative care2025

DOI: 10.1136/spcare-2023-004609 PMID: 38160047

Busulfan with 400 centigray of total body irradiation and higher dose fludarabine: An alternative regimen for hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia.

Gharial J, Guilcher G, Truong T, Shah R, Desai S, Rojas-Vasquez M, Kangarloo B, Lewis V

Pediatric blood & cancer2024Senior author

DOI: 10.1002/pbc.30844 PMID: 38217082

Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy

Halton JM, Ma J, Babyn P, Matzinger MA, Kaste SC, Scharke M, Fernandez CV, Miettunen P, Ho J, Alos N

Journal of Bone and Mineral Research20239 citations

DOI: 10.1002/jbmr.4870

Evaluation of a pediatric pre-chemotherapy rapid hydration protocol: A quality assurance project.

McKinnon K, Tran T, Lewis V

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2023Senior author

DOI: 10.1177/10781552221078207 PMID: 35156868

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Adenine Base Editing Dear Professor Lewis, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency." (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Victor Lewis

Research

Latest papers

Latest funding

Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

IL1B rs1143627 and IL17A rs8193036 in the risk of Acute Graft Versus Host Disease in pediatric HSCT.

Approach to red cell transfusions and stem cell transplant in an alloimmunized sickle cell patient with hyperhemolysis history.

Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children's Oncology Group study ACNS0333.

HLA-B*15:01 and HLA-DRB1*07:01 as novel markers of acute GVHD in pediatric HSCT.

Yoga versus iPad active control for fatigue in paediatric cancer therapy: a randomised controlled trial.

Busulfan with 400 centigray of total body irradiation and higher dose fludarabine: An alternative regimen for hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia.

Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy

Evaluation of a pediatric pre-chemotherapy rapid hydration protocol: A quality assurance project.

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

The Pain Squad+ Smartphone App To Support Real-Time Pain Management for Adolescents with Cancer: A Randomized Controlled Trial

Frequent collaborators

Lillian Sung

Daniel Sinnett

Sonia Cellot

Aru Narendran

Joseph Beyene

Helen Trottier

Jacques Lacroix

Marisa Tucci

Michel Duval

Donna Johnston

Suzanne Vercauteren

Celia Rodd

Ronald Duncan Barr

Josephine Ho

Frank Rauch

Stephanie Atkinson

Luis Murguia-Favela

Pierre Billon

Eleanor Pullenayegum

Kevin Hay

Mona Shafey

Paul Babyn

David Cabral

Ramy Saleh

Jennifer Quizi

Uma Athale

Jinhui Ma

HLA-B15:01 and HLA-DRB107:01 as novel markers of acute GVHD in pediatric HSCT.